스노우투플러스

전체상품목록 바로가기

본문 바로가기

+5000POINT

prev next

MEMBERSHIP

신규가입시 드리는 선물.5000p가져가세요.

바로가기+

prev next

[리뉴얼기념 30개 한정 75%할인] 마그네슘 마이크로 캐리어 - 멀티케어 세트

138000 won

[리뉴얼기념 30개 한정 75%할인] 마그네슘 마이크로 캐리어 - 아이케어 세트

136000 won

신상품

Enjoy Your Happy And Stylish Shopping!

상품명 : [스노우투플러스] 페이셜 멀티 케어 포 스킨 트러블 솔루션

판매가 : 19,800원

모델 : C118
상품명 : [스노우투플러스] 페이셜 스팟 케어 포 스킨 트러블 솔루션

판매가 : 22,800원

모델 : C117
상품명 : 멜라스노우 마그네슘 기미패치

판매가 : 24,800원

BRAND VIDEO

MD추천상품

Enjoy Your Happy And Stylish Shopping!

상품명 : [스노우투플러스] 페이셜 마그네슘 주름/미백 멀티패치

판매가 : 19,800원

모델 : C130
상품명 : [스노우투플러스] 페이셜 마그네슘 주름/미백 아이존패치

판매가 : 22,800원

모델 : C129

인스타그램

가장 혁신적인 홈케어

스노우투플러스 인스타그램을 팔로우하고 최신 컨텐츠를 감상하세요
바로가기

포토후기 작성하자!

추첨을 통해 소정의 선물을 드려요~

사용하고 있는 제품의 장점을 써주시고
제품사용컷 사진도 함께 찰칵 찍어주세요
바로가기

PHOTO REVIEW

ENJOY YOUR SHOPPING

딱 봐도 알수있는 전과 후의 차이 파인부분이 부풀어오르고 살아나네요~
패치도 붙이고 팩도하고 ! 마그네슘 패치와 촉촉해지는 마스크팩 때문에 피부가 열배는 좋아지는거 같아요
반짝 반짝 마그네슘패치~~ 믿음직스러운 반짝임이 확실히 효과를 보여주네요 >.<
눈에 보이는 확실한 효과! 눈에 띄게 차이날 정도로 달라지네요 ~
예쁜 핑크케이스에 효과도 확실하네요 확실한 케어가 되는듯 하네요 ㅎㅎ
눈가 주름이 옅어졌어요 1회사용으로 눈가주름이 옅어졌어요신기하네요 꾸준히 사용해야겠어요!
피부속부터 케어되는 느낌이예요 피부 속까지 침투되는 모습이 진짜 보이니까속부터 케어되는 느낌이예요~
에이프릴 채경이 스노우 투 플러스 체험기
스노우 투 플러스 체험
좁쌀여드름 해결 너무좋아요~

상품Q &A

질문 & 답변
제목	날짜
입급 확인 좀 해주세요	2020/10/05
주소는 어떻게 하나요?	2020/07/28
입금확인부탁드려요.	2020/07/22
리뷰링크가 없던데...	2020/07/21
++	2020/07/19

랩앤피플 NEWS

[동아닷컴] AC 마그네슘 니들 패치 출시…올랩앤피플㈜은 최근 출시한 AC 마그네슘 니들 패치(AC Magnesium NEEDLE PATCH)가 올리브영 매장에 공식 입점했다고 22일 밝혔다.회사 측에 따르면 AC 마그네슘 니들 패치는 전 성분이 99% 마그네슘으로 이루어진 마이크로 니들 형태의 패치로여드름 병변에 부착해 개선 효과를 볼 수 있다.마그네슘이 피부 속 수분과 만나 수소를 발생시켜 트러블 케어와 항산화 효과를 구현하도록 한 제품이다.마그네슘 패치를 얼굴에 부착할 수 있도록 하이드로콜로이드 밴드를 사용했는데,하이드로콜로이드 밴드는 습윤환경을 조성해 상처 부위의 삼출물을 빠르게 흡수하는 것이 특징이다.여드름성 피부 사용 적합성 평가를 위해 인체적용시험을 진행한 결과참가자 전원이 여드름 개선 효과 항목에서 만족 이상의 긍정평가를 했다고 업체 측은 전했다.사용방법은 간단하다. 세안 후 피부결을 정돈한 후 패치의 보호 필름을 제거한 후니들 부분이 피부에 닿도록 부착한 후 2~8시간 후에 제거하면 된다.조성윤 대표는 “최근 코로나19로 마스크 사용이 증가하면서 각종 피부 트러블 및 여드름을 호소하는 이가 늘고 있다”며“AC 마그네슘 니들 패치는 이를 해결해줄 제품이다”라고 했다.이어 “세계 최초로 생체 흡수성 금속인 마그네슘을 이용한 마이크로 니들패치를 개발해 시중의 니들패치와 차별화했다”고 덧붙였다.박해식 동아닷컴 기자 pistols@donga.com

[코리아타임스] Seoul BioHub bui Seoul BioHub, opened in October 2017, is leading the country's biomedical science industry./Courtesy of Seoul BioHubBy Kim Se-jeong In the 1960s and 70s, Korea's high-end science and technology industry was led by the Hongneung region of northeastern Seoul. The area housed universities ― Korea University, Kyunghee University and the Korea Institute of Science and Technology (KIST) ― as well as engineers and scholars, who together led innovations in the developing country.Half a century later, the area is rebranding itself as the nation's center for biomedical science. The Seoul Metropolitan Government is the force behind the movement, with a vision to make the country's capital a biomedical cluster both for the nation, and for Asia. To begin, Seoul city purchased property from the Korea Rural Economic Institute ― the institute relocated itself to Naju, South Jeolla Province, in 2015 ― and transformed it into the Seoul BioHub.Upon its official launch in October 2017, the city joined hands with the Korea Health Industry Development Institute (KHIDI) to oversee management and operation.Seoul BioHub is currently home to 68 startup companies across the biomedical industry. The startup Bioway develops pancreatic and hepatocellular tumor drugs, while Ilias Biologics conducts research into the treatment of sepsis. LABnPEOPLE develops microneedles and other bio-absorbable materials, and HUINNO creates wearable electrocardiograms for arrhythmia patients.Seoul BioHub offers office and lab space to the resident companies at below-market prices, while providing workshops across areas such as accounting, patents, trademark applications and biopharmaceutical R&D. _ workshops are also open to non-resident companies which need help. Resident companies can stay in the BioHub for maximum four years. "We welcome startups with strong ideas and technologies," Kang Dae-wook, Seoul BioHub's general director told The Korea Times. But, one important pre-requisite is that the company's product contributes to improving human health. "Seoul BioHub's support is geared toward improving human lives. Any company in the biotechnology, medical technology and health technology can apply."The hub boasts an optimal location, with nine universities, six medical centers and nine research institutes within the vicinity. "Hongneung is an area of major research centers, universities and hospitals," said Kang. "It's the perfect site for Seoul BioHub."Seoul BioHub is part of the Hongneung Biomedical Cluster spearheaded by the city government.This year, Center for Integrating BT-IT will open close to the BioHub."Seoul City is supporting and nurturing the biomedical industry in the city," Kang said.The city's campaign to support biomedical companies is in line with global developments in the healthcare sector, driven in part by a growing and aging population. Focus on chronic diseases is shifting towards prevention, and early detection. In Korea, the healthcare sector is viewed by many as a pillar that will drive Korea's economic prosperity. With this in mind, the government undertook policy reform and granting increased financial support to the private healthcare sector.The central government also runs Osong Biovalley in Cheongju, North Chungcheong Province and Wonju Medical Industry Technovalley in Wonju, Gangwon Province to support promising young companies. Last year, the central government also introduced strategies aimed at nurturing healthcare industries and, earlier this month, it announced the decision to remove certain key regulations in order to establish a more level playing field for related companies. "The world's pharmaceutical market has grown by 6 percent every year since 2005, reaching $1.14 trillion in 2017. In 2020, the figure is expected to reach $1.43 trillion, which is higher than the semi-conductor and aerospace sectors combined," Kang said. He also pointed out that the biomedical industry creates two times as many jobs as the manufacturing industry, and the quality of its employment is also high. Johnson & Johnson ― an international corporation developing medical devices, pharmaceutical and consumer packaged goods ― is Seoul BioHub's business partner. Johnson & Johnson helps discover startups deemed to have potential and sometimes purchase a company developing promising technology. 'Seoul Innovation QuickFire Challenge' is an annual contest organized by Johnson & Johnson, together with the city government and the KHIDI, which awards companies with the promising medical technologies. This year will see the fourth round of the contest in Korea. In addition to Johnson & Johnson, the Swiss healthcare company Novartis, and American pharmaceutical company MSD, are also partners of Seoul BioHub. 'We want to stay here as long as possible' LABnPEOPLE CEO Cho Sung-younFounded in 2016, LABnPEOPLE develops microneedles and bioabsorbable materials, and was one of the first groups to reside in Seoul BioHub.CEO Cho Sung-youn praised Seoul BioHub's convenient location."It's right in the middle of the city," said Cho. Prior to Seoul BioHub, LABnPEOPLE was headquartered in Yangju, Gyeonggi Province, and so Cho knows well the benefits of having a central office."I need to hire quality researchers, but that's difficult when the office is located outside of Seoul. I also have to meet with investors and research partners who are mostly based in the city. Having an office in the city is important for businesses," Cho said. LABnPEOPLE works with research partners at both Korea University and KIST. The company also develops minimally invasive devices used to treat spinal stenosis, and microneedles in patch-form with anti-acne and anti-wrinkle properties. The anti-acne patch will soon go on sale at Olive Young - a major health and beauty store - and the anti-wrinkle patch is currently distributed in Japan.Last year, LABnPEOPLE saw sales of approximately 100 million won. "Despite the ongoing coronavirus concerns, we project bigger profits this year," Cho said. LABnPEOPLE CEO hailed Seoul BioHub's "All-in-One designated consulting," a service customized to individual companies for its quality.

NOTICE & NEWS

NOTICE & NEWS
제목 날짜

LABnPEOPLE COSMETICS
스노우투플러스로 특별한 홈케어 고농도 히알루론산 앰플로 주름개선/미백 2중 기능성 화장품입니다.

Snow2plus Niddle Patch Skin Steps 시간에 흐름에 따라 변화하는 나의 피부를 느껴보세요. 지금도 변화하고 있습니다.

스우투플러스의 네이버 블로그 체험단 장안의 화제 스노우투플러스!! 뷰티 블로거들의 생생한 체험후기를 느껴보세요.

스노우투플러스의 새로운 쇼핑몰이 나왔습니다. 언제나 친절하게 답변해드리겠습니다. 제품에 대한 문의사항 부담없이 전화주세요

장바구니 0개
최근 본 상품
- ##name##
- ##name##

070-4230-0204

1:1문의하기

MAGAZINE

WEEKDAY : AM 09:00~PM 06:00 | LUNCH : PM 12:30~PM 01:30 | ClOSED : Saturday, Sunday and holidays.

신한은행 100-031-530242 | 예금주 : 랩앤피플주식회사

- 법인명(상호) : 랩앤피플㈜ | 대표자 : 조성윤 | CPO : 왕예은
- 주소 : (11477) 경기도 양주시 옥정로 46-121 (옥정동) | 전화 : 031-846-0204 | 팩스 : 031-847-0204
- 사업자등록번호 : 644-88-00230 | 통신판매신고번호 : 제2017-경기양주-0071호 [사업자정보확인] | 개인정보관리책임자 : 왕예은(yewang@labnp.com)
- RETURN & EXCHANGE (교환 및 반품)주소 : 경기도 양주시 옥정로 46-121(옥정동)
- Copyright © LABnPEOPLE.. All rights reserved.

전체상품목록

MEMBERSHIP

신상품

BRAND VIDEO

MD추천상품

인스타그램

포토후기 작성하자!

PHOTO REVIEW

상품Q &A

랩앤피플 NEWS

NOTICE & NEWS

최근 본 상품